FDA Needs External Board Of Directors, Former Commish von Eschenbach Says
Executive Summary
Cleveland Clinic’s Steve Nissen calls for new marketing exclusivity, while FDA’s Hamburg cites agency’s openness to biomarkers, innovative clinical trial designs in forum on how to enhance the agency’s performance.